The Swine Fever Vaccine Market is estimated to be valued at US$ 2885.25 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Swine fever vaccines help prevent swine fever, also known as hog cholera, in pigs. The disease threatens pork production and farm economies globally. The commonly used vaccines are live attenuated vaccines and inactivated vaccines. Live attenuated vaccines provide strong immunity for a longer duration as compared to inactivated vaccines. Pigs get vaccinated at an early stage to prevent outbreaks.

Market Dynamics:

One of the key drivers for the swine fever vaccine market growth is outbreaks of African swine fever virus in various regions. There have been outbreaks of African swine fever in China, Eastern Europe, and Southeast Asia in recent years which has resulted in steep losses for pig farmers. This has increased the adoption of vaccination programs to curb the spread of the disease. Secondly, the increasing demand for pork meat is also boosting the market. With rising incomes, pork consumption has risen globally leading to expansion of pork production. Vaccination ensures higher yields and quality pork production.

Segment Analysis:

The swine fever vaccine market is dominated by live attenuated vaccines segment due to high efficacy in preventing disease spread. Live attenuated vaccines help develop adequate immunity against viral strains without causing disease. They are more effective in inducing protective immunity and long lasting immunity, hence adopted widely by farmers.

PEST Analysis:

• Political: Regulations regarding swine production and vaccination are conducive for market growth. Farm subsidy policies favor livestock immunization programs.
• Economic: Rising pork demand globally is prompting increased livestock production. Vaccination programmes optimize productivity and profits.
• Social: Swine farmers recognize their responsibility to prevent disease transmission. Social awareness about animal welfare boosts preventive healthcare adoption.
• Technological: Advanced adjuvants, delivery methods and antigen production techniques improve vaccine safety and effectiveness. Digital tools facilitate efficient vaccination program management.

Key Takeaways:

The Global Swine Fever Vaccine Market Growth is expected to witness high, exhibiting CAGR of 5.9% over the forecast period, due to increasing pork consumption worldwide. The market size is valued at US$ 2885.25 Mn in 2023.

Regional analysis: Asia Pacific dominates the market and is expected to grow the fastest due to a large pork industry and frequent outbreaks in key markets like China and Vietnam. The region accounts for over 50% of global pork production.

Key players operating in the Swine Fever Vaccine market are Merck & Co., Inc. (Merck Animal Health), Ceva, Zoetis Services LLC, Boehringer Ingelheim International GmbH, Indian Immunologicals Ltd., Bioveta, a.s., Komipharm, and EC21 Inc. Key players are focused on developing novel adjuvants and recombinant vaccines to address varied circulating strains of the virus.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it